Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02030964
Title N2012-01 Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
Acronym DFMO
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027-0700 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
Children Hospital of Colorado Aurora Colorado 80045 United States Details
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta Georgia 30322 United States Details
University of Chicago Comer Children's Hospital Chicago Illinois 60637 United States Details
Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-4318 United States Details
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104 United States Details
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 United States Details
Sydney Childrens Hospital KCC Randwick 2031 Australia Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field